NASDAQ: ICGIntchains Group Ltd Stock
$3.67-0.13 (-3.42%)
Updated Mar 18, 2025
ICG Price
$3.67
Fair Value Price
$1.23
Market Cap
$220.13M
52 Week Low
$2.80
52 Week High
$12.04
P/E
4.17x
P/B
0.22x
P/S
0.7x
PEG
0.11x
Dividend Yield
N/A
Revenue
$281.77M
Earnings
$51.50M
Gross Margin
53.7%
Operating Margin
17.81%
Profit Margin
18.3%
Debt to Equity
0.08
Operating Cash Flow
N/A
Beta
1.15
Next Earnings
May 15, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ICG Overview
Intchains Group Limited designs and sells application-specific integrated circuit chips and ancillary software and hardware for blockchain applications in the People's Republic of China. It serves distributors, companies, and individuals. Intchains Group Limited was founded in 2017 and is based in Pudong, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ICG's potential to beat the market
- ICG doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Semiconductor
Industry Rating
D
ICG
RankedUnranked of 67
RankedUnranked of 67
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $38.65 | B | |
| $68.28 | B | |
| $19.18 | B |
Be the first to know about important ICG news, forecast changes, insider trades & much more!
ICG News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ICG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ICG ($3.67) is overvalued by 199.08% relative to our estimate of its Fair Value price of $1.23 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ICG ($3.67) is not significantly undervalued (199.08%) relative to our estimate of its Fair Value price of $1.23 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ICG ($3.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ICG due diligence checks available for Premium users.
Valuation
ICG fair value
Fair Value of ICG stock based on Discounted Cash Flow (DCF)
Price
$3.67
Fair Value
$1.23
Overvalued by
199.08%
ICG ($3.67) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ICG ($3.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ICG ($3.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ICG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
4.17x
Industry
44.74x
Market
30.9x
ICG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ICG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ICG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.22x
Industry
8.53x
ICG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ICG price to earnings growth (PEG)
For valuing profitable companies with growth potential
ICG is good value based... subscribe to Premium to read more.
PEG Value Valuation
ICG's financial health
Profit margin
Revenue
$74.2M
Net Income
$12.8M
Profit Margin
17.2%
ICG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.1B
Liabilities
$76.4M
Debt to equity
0.08
ICG's short-term assets ($720.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICG's short-term assets ($720.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ICG vs Semiconductor Stocks
Intchains Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.